جارٍ التحقق…
تُرجمت تلقائيًا. للجرعات والتحذيرات: راجع النص الأصلي بالإنجليزية. اقرأ بالإنجليزية
الرئيسية / Registered in Nigeria / Cobas E411 Analyzer

Cobas E411 Analyzer

NAFDAC Reg. No. A3-100643 · Drug

Registered with NAFDAC. Registration activeAs of 29 October 2026 · synced automatically from official sources.
Product
Cobas E411 Analyzer
رقم NAFDAC
A3-100643
المادة الفعالة
Blood Analyzer
التركيز
NA
الشكل
NA
حجم العبوة
1 unit per pack
Manufacturer
Not listed
Applicant (holder)
Roche Products Limited
Approved
31 May 2022
الحالة
Active View on NAFDAC ↗
التسجيل ساري حتى
25 May 2027
تنبيهات منظمة الصحة العالمية
None found
Community reports
None
Times checked
0

About the medicine: Blood analyzer: uses, dosage and brands worldwide

What we found

  • Cobas E411 Analyzer is on the NAFDAC register with an active registration (A3-100643). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Cobas E411 Analyzer

ما تقوله النشرة الرسمية. إذا وصفه لك طبيب، فاتبع الوصفة. وإذا اختلفت نشرة عبوتك، فالأولوية لها.

لمن هو

HCB-Res For the temporary relief of dizziness, weakness, and shortness of breath associated with heart irregularity and angina.

كيف يُتناول وكم مرة
  • HCB-Res Orally 25 drops, 2 times per day or as indicated by a physcian
  • Children 12 and under use one half the adult dosage
Warnings

HCB-Res Use only under direction of a health care professional. Do not use if tamper evident seal is broken or missing.

How to store it

Keep out of reach of children.

إذا نسيت جرعة

تناولها عندما تتذكر، إلا إذا اقترب موعد الجرعة التالية. عندها تخطَّ الجرعة المنسية. لا تتناول جرعتين معًا أبدًا للتعويض. راجع النشرة، فبعض الأدوية مختلفة.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-12-17.

Label for blood analyzer, the active ingredient registered with NAFDAC.

Check your pack of Cobas E411 Analyzer

Add the expiry date on your pack for a full Trust Score.

أو التقط صورًا للعبوة
تبقّت 3 عمليات تحقق مجانية اليوم المصادر الرسمية: FDA الأمريكية · EMA (الاتحاد الأوروبي) · NAFDAC · تنبيهات منظمة الصحة العالمية

About Cobas E411 Analyzer

What is in Cobas E411 Analyzer?

Cobas E411 Analyzer contains Blood Analyzer (NA), as na, according to its NAFDAC registration record.

Is Cobas E411 Analyzer registered with NAFDAC?

Yes. Cobas E411 Analyzer is listed on the NAFDAC register under registration number A3-100643, and its registration is active as of 29 October 2026.

Has Cobas E411 Analyzer been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Cobas E411 Analyzer in our automatically synced alert list.

How can I check that my pack of Cobas E411 Analyzer is genuine?

Run a free authenticity scan with the NAFDAC number A3-100643, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Cobas E411 Analyzer?

Follow your prescription or the leaflet in your pack. The official label says: HCB-Res Orally 25 drops, 2 times per day or as indicated by a physcian. Children 12 and under use one half the adult dosage.…

What is Cobas E411 Analyzer used for?

HCB-Res For the temporary relief of dizziness, weakness, and shortness of breath associated with heart irregularity and angina. (Summarised from the official U.S. FDA label for blood analyzer. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Cobas E411 Analyzer? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.